These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 34757578)

  • 1. Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Ngamprasertchai T; Kajeekul R; Sivakorn C; Ruenroegnboon N; Luvira V; Siripoon T; Luangasanatip N
    Infect Dis Ther; 2022 Feb; 11(1):231-248. PubMed ID: 34757578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis.
    Cherian JJ; Eerike M; Bagepally BS; Das S; Panda S
    Front Pharmacol; 2022; 13():1004308. PubMed ID: 36330085
    [No Abstract]   [Full Text] [Related]  

  • 3. The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis.
    Zhang X; Shang L; Fan G; Gu X; Xu J; Wang Y; Huang L; Cao B
    Front Med (Lausanne); 2021; 8():800492. PubMed ID: 35155477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis.
    Niu J; Lin Z; He Z; Yang X; Qin L; Feng S; Guan L; Zhou L; Chen R
    Front Med (Lausanne); 2022; 9():973688. PubMed ID: 36507538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies.
    Yan D; Fan H; Chen M; Xia L; Wang S; Dong W; Wang Q; Niu S; Rao H; Chen L; Nie X; Fang Y
    Front Pharmacol; 2022; 13():950450. PubMed ID: 36091777
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis.
    Tanaka Y; Okumura H; Kim S; Dorey J; Wojciechowski P; Chorąży J; Kato D; Schultz NM
    Rheumatol Ther; 2021 Jun; 8(2):729-750. PubMed ID: 33725321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial Infections in COVID-19 Patients Treated with Immunomodulators: A Narrative Review.
    Ramasamy C; Narayan G; Mishra AK; John KJ; Lal A
    Front Biosci (Schol Ed); 2022 Sep; 14(4):26. PubMed ID: 36575837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials.
    Patoulias D; Doumas M; Papadopoulos C; Karagiannis A
    Clin Rheumatol; 2021 Nov; 40(11):4671-4674. PubMed ID: 34431004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review.
    Wang Y; Zhu K; Dai R; Li R; Li M; Lv X; Yu Q
    Front Pharmacol; 2021; 12():804250. PubMed ID: 35126138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis.
    Zhang L; Du D; Wang L; Guo L; Jiang X
    J Dermatol; 2021 Dec; 48(12):1877-1883. PubMed ID: 34487567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis.
    Wijaya I; Andhika R; Huang I; Purwiga A; Budiman KY; Bashari MH; Reniarti L; Roesli RMA
    Clin Epidemiol Glob Health; 2021; 11():100755. PubMed ID: 33969237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis.
    Weng C; Xue L; Wang Q; Lu W; Xu J; Liu Z
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X21999564. PubMed ID: 33815570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials.
    Selvaraj V; Finn A; Lal A; Khan MS; Dapaah-Afriyie K; Carino GP
    EClinicalMedicine; 2022 Jul; 49():101489. PubMed ID: 35677732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and network meta-analysis.
    Zhang L; Wang L; Jiang X
    Dermatol Ther; 2021 Sep; 34(5):e15098. PubMed ID: 34392600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19.
    Florescu DF; Kalil AC
    Curr Opin Crit Care; 2021 Oct; 27(5):493-496. PubMed ID: 34353999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.